PM2 PM2 > > (Pramipexole dihydrochloride 0.25 mg)
Pill imprint PM2 PM2 > > has been identified as Pramipexole dihydrochloride 0.25 mg.
Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for PM2 PM2 > > (Pramipexole dihydrochloride 0.25 mg)
- 0.25 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
silicon dioxide colloidal
Pramipexole dihydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...